Related Experiment Video
Updated: May 16, 2025

A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors
Published on: June 8, 2022
Bioinformatics exploration of the S1PR1 receptor in various human cancers and its clinical relevance
Xing Xiong1, Li Zeng2, Fanhui Zeng3
1Department of Urology Surgery, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, 330006, China.
Background And Objective:
S1PR1 (sphingosine-1-phosphate receptor 1) plays a critical role in key cancer-related processes such as cell migration, proliferation, and survival. While its functions are well-established in the cardiovascular and immune systems, its mechanism in cancer remains unclear. Our study aims to investigate the expression, mutations, post-translational modifications, and immune infiltration of S1PR1 across different cancers, and particularly focus on its potential as a therapeutic target and prognostic biomarker.
Methods:
We utilized HPA, GTEx, TCGA and CPTAC bioinformation databases to evaluate the expression level of S1PR1 between normal and cancer tissue. Sequence conservation and phylogenetic analysis of S1PR1 are assessed by NCBI and Pfam database. Gene mutations, methylation, phosphorylation, and immune infiltration of S1PR1 were analyzed by cBioPortal, MethSuv, CPTAC and TIMER2.0 respectively.
Results:
S1PR1 expression varied significantly among cancers, with decreased levels in bladder and breast cancers, and increased levels in renal cell carcinoma, thyroid cancer, and acute myeloid leukemia. Mutation analysis revealed frequent mutations in endometrial, lung, and ovarian cancers. Reduced methylation in lung adenocarcinoma correlated with improved survival. Elevated phosphorylation was observed in glioblastoma and renal carcinoma. Immune infiltration analysis showed significant correlations with CAFs and γδ T cells.
Conclusion:
S1PR1 plays a critical role in cancer progression through its expression, mutations, and modifications. These findings suggest that S1PR1 could be served as a potential biomarker and therapeutic target in cancer, but it need a further validation in clinical settings is warranted.
Insights
Sphingosine-1-phosphate receptor 1 (S1PR1) is crucial in cancer progression. Its expression, mutations, and modifications suggest S1PR1 is a potential therapeutic target and prognostic biomarker for various cancers.
Area of Science:
- Oncology
- Molecular Biology
- Bioinformatics
Background:
- Sphingosine-1-phosphate receptor 1 (S1PR1) is vital for cell migration, proliferation, and survival.
- Its role in cancer pathogenesis is not fully understood, unlike its established functions in cardiovascular and immune systems.
Purpose of the Study:
- To investigate the expression, mutations, post-translational modifications, and immune infiltration of S1PR1 across diverse cancer types.
- To evaluate S1PR1's potential as a therapeutic target and prognostic biomarker in oncology.
Main Methods:
- Utilized bioinformatics databases (HPA, GTEx, TCGA, CPTAC) for S1PR1 expression analysis.
- Assessed sequence conservation and phylogenetic analysis via NCBI and Pfam.
- Analyzed gene mutations, methylation, phosphorylation, and immune infiltration using cBioPortal, MethSuv, CPTAC, and TIMER2.0.
Main Results:
- S1PR1 expression varied significantly across cancers, with notable decreases in bladder/breast cancers and increases in renal cell carcinoma, thyroid cancer, and acute myeloid leukemia.
- Frequent S1PR1 mutations were found in endometrial, lung, and ovarian cancers. Reduced methylation in lung adenocarcinoma correlated with better survival.
- Elevated S1PR1 phosphorylation occurred in glioblastoma and renal carcinoma, with immune infiltration linked to cancer-associated fibroblasts (CAFs) and γδ T cells.
Conclusions:
- S1PR1's expression, mutations, and modifications critically influence cancer progression.
- S1PR1 emerges as a promising biomarker and therapeutic target, warranting further clinical validation.
More Related Videos
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
08:29Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
Published on: October 2, 2014
Related Concept Videos
Mitogens and the Cell Cycle
Abnormal Proliferation
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
The Ras Gene
Ras is a...
Selectins
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...